Home > Qtrly Results > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Quarterly Results Analysis [Mar2026]

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
Audited
Sep2024
Audited
Jun2024
UnAudited
Revenues ₹52 Cr ₹66 Cr ₹44 Cr ₹284 Cr ₹52 Cr ₹37 Cr ₹32 Cr ₹244 Cr
Expenses ₹47 Cr ₹62 Cr ₹38 Cr ₹245 Cr ₹52 Cr ₹29 Cr ₹27 Cr ₹207 Cr
Operating Income ₹4 Cr ₹4 Cr ₹6 Cr ₹38 Cr ₹0 Cr ₹8 Cr ₹5 Cr ₹37 Cr
Other Income ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹4 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹5 Cr ₹5 Cr ₹4 Cr ₹3 Cr ₹1 Cr ₹4 Cr ₹3 Cr ₹2 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹2 Cr ₹2 Cr ₹3 Cr ₹36 Cr ₹2 Cr ₹4 Cr ₹1 Cr ₹34 Cr
Profit After Tax ₹0 Cr ₹2 Cr ₹3 Cr ₹35 Cr ₹1 Cr ₹3 Cr ₹1 Cr ₹33 Cr
EPS ₹0.00 ₹0.84 ₹1.45 ₹19.62 ₹0.78 ₹1.39 ₹0.59 ₹17.55
Industry Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) 3.9% -2.3% -17.3%
KAVERI SEED COMPANY 9% 3% -26.5%
VENKYS (INDIA) -0.4% -6.5% -10.8%
AVT NATURAL PRODUCTS -3.4% 2.2% 8.2%
BOMBAY SUPER HYBRID SEEDS -2.4% -8.8% NA
MANGALAM GLOBAL ENTERPRISE 1.6% 17.7% 13.6%
INDO US BIOTECH -1.4% -11.9% -41.4%
JK AGRI GENETICS -5.3% -9.7% -21%
MANGALAM SEEDS -1.4% -10.6% -29.9%

NATH BIOGENES (INDIA) Quarterly Revenues

Revenues
Q-o-Q

-21.78 %

Y-o-Y

-0.72 %

Quarters Revenues % Change
Mar2026 ₹52 Cr
-21.78
Dec2025 ₹66 Cr
50.42
Sep2025 ₹44 Cr
-84.54
Jun2025 ₹284 Cr
445.91
Mar2025 ₹52 Cr
40.94
Dec2024 ₹37 Cr
14.54
Sep2024 ₹32 Cr
-86.80
Jun2024 ₹244 Cr -

NATH BIOGENES (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

25.29 %

Y-o-Y

984.26 %

Quarters Operating Profit % Change
Mar2026 ₹4 Cr
25.29
Dec2025 ₹4 Cr
-41.44
Sep2025 ₹6 Cr
-84.06
Jun2025 ₹38 Cr
9,169.73
Mar2025 ₹0 Cr
-94.86
Dec2024 ₹8 Cr
67.01
Sep2024 ₹5 Cr
-86.83
Jun2024 ₹37 Cr -
Operating Margins
Q-o-Q

60.15 %

Y-o-Y

998.73 %

Quarters Operating Margin% % Change
Mar2026 8.68%
60.15
Dec2025 5.42%
-61.06
Sep2025 13.92%
3.19
Jun2025 13.49%
1,607.59
Mar2025 0.79%
-96.38
Dec2024 21.8%
45.82
Sep2024 14.95%
-0.20
Jun2024 14.98% -

NATH BIOGENES (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Mar2026 ₹0 Cr
Negative
Dec2025 ₹2 Cr
-41.66
Sep2025 ₹3 Cr
-92.18
Jun2025 ₹35 Cr
3,646.49
Mar2025 ₹1 Cr
-64.54
Dec2024 ₹3 Cr
137.97
Sep2024 ₹1 Cr
-96.66
Jun2024 ₹33 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Mar2026 -0.02 %
Negative
Dec2025 2.43 %
-61.31
Sep2025 6.28 %
-49.40
Jun2025 12.41 %
585.64
Mar2025 1.81 %
-74.83
Dec2024 7.19 %
107.80
Sep2024 3.46 %
-74.71
Jun2024 13.68 % -

NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-100.00 %

Y-o-Y

-100.00 %

Quarters EPS % Change
Mar2026 ₹0
-100.00
Dec2025 ₹0.84
-42.07
Sep2025 ₹1.45
-92.61
Jun2025 ₹19.62
2,415.38
Mar2025 ₹0.78
-43.88
Dec2024 ₹1.39
135.59
Sep2024 ₹0.59
-96.64
Jun2024 ₹17.55 -

You may also like the below Video Courses